Literature DB >> 34718208

Deep learning in target prediction and drug repositioning: Recent advances and challenges.

Jun-Lin Yu1, Qing-Qing Dai1, Guo-Bo Li2.   

Abstract

Drug repositioning is an attractive strategy for discovering new therapeutic uses for approved or investigational drugs, with potentially shorter development timelines and lower development costs. Various computational methods have been used in drug repositioning, promoting the efficiency and success rates of this approach. Recently, deep learning (DL) has attracted wide attention for its potential in target prediction and drug repositioning. Here, we provide an overview of the basic principles of commonly used DL architectures and their applications in target prediction and drug repositioning, and discuss possible ways of dealing with current challenges to help achieve its expected potential for drug repositioning.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep learning; Drug discovery; Drug repositioning; Drug–target interaction; Heterogeneous network; Target prediction

Mesh:

Year:  2021        PMID: 34718208     DOI: 10.1016/j.drudis.2021.10.010

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   8.369


  6 in total

1.  An Integrative Heterogeneous Graph Neural Network-Based Method for Multi-Labeled Drug Repurposing.

Authors:  Shaghayegh Sadeghi; Jianguo Lu; Alioune Ngom
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

2.  DeepMHADTA: Prediction of Drug-Target Binding Affinity Using Multi-Head Self-Attention and Convolutional Neural Network.

Authors:  Lei Deng; Yunyun Zeng; Hui Liu; Zixuan Liu; Xuejun Liu
Journal:  Curr Issues Mol Biol       Date:  2022-05-19       Impact factor: 2.976

3.  Drug repurposing: An effective strategy to accelerate contemporary drug discovery.

Authors:  Peng Zhan; Bin Yu; Liang Ouyang
Journal:  Drug Discov Today       Date:  2022-05-31       Impact factor: 8.369

Review 4.  Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents.

Authors:  Sha Zhu; Qifeng Bai; Lanqing Li; Tingyang Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-01       Impact factor: 6.155

Review 5.  A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discovery.

Authors:  Saeid Maghsoudi; Bahareh Taghavi Shahraki; Fatemeh Rameh; Masoomeh Nazarabi; Yousef Fatahi; Omid Akhavan; Mohammad Rabiee; Ebrahim Mostafavi; Eder C Lima; Mohammad Reza Saeb; Navid Rabiee
Journal:  Chem Biol Drug Des       Date:  2022-09-22       Impact factor: 2.873

Review 6.  Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis.

Authors:  Viktor A Zouboulis; Konstantin C Zouboulis; Christos C Zouboulis
Journal:  Pharmaceutics       Date:  2021-12-26       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.